Routine identification of commonly isolated yeast in clinical microbiology;Comparación de métodos para la identificación de las levaduras más frecuentes en el laboratorio de microbiología clínica

Revista Argentina de Microbiologia

Volumn 35, Issue 1, 2003, Pages 49-53

  Guelfand, L ^a   Grisolia, P ^a   Bozzano, C ^a   Kaufman, S ^a  

^a HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

Author keywords

Candida; CHROMagar Candida; Morphology agar; Vitek; Yeast identification

Indexed keywords

ACCURACY; ARGENTINA; ARTICLE; CANDIDA; CRYPTOCOCCUS NEOFORMANS; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MORPHOLOGY; NONHUMAN; PRACTICE GUIDELINE; STANDARD;

AUTOMATION; CANDIDA; CANDIDIASIS; CHROMOGENIC COMPOUNDS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIA; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

EID: 0037809554     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Anaissie E (1992) Opportunistic mycoses in the immuno-compromised host: experience at a cancer center and review. Clin. Infect. Dis.14 (suppl): S43-S53.
2. Bouchara JP, Decler C, Krusei P, Cimon B, Planchenault C, Gentile L, Chabasse D (1996) Routine use of CHROMagar C. medium for presuntive identification of C. yeast species. Clin. Microbiol. Infect. 2: 202-208.
3. Buchaille I, Freydi'ere AM, Guinet R, Gille Y (1998) Evaluation of six commercial systems for identification of medical important yeast. Eur. J. Clin. Microbiol. Infect. Dis. 17: 479-488.
4. Carillo Munoz A, Quindoz G, Cardenes C, Vargas R, Arevalo P, Brio S, Madaríaga L (2001) Evaluación del medio Chromalbicans Agar para la identificación presuntiva de C. albicans. Rev. Iberoam. Micol. 18: 105-108.
5. Champs C, Lebeau B, Ambroise T, Grillot R (1995) Evaluation of Albicans ID plates. J. Clin. Microbiol. 33: 2227-2228.
6. Dooley DP, Beius M, Jeffrey B (1994) Misidentification of clinical yeast isolates by using Vitek biochemical card. J. Clin. Microbiol. 32: 2889-2892.
7. El-Zaatari M, Pasarell L, McGinis M, Buner J, Land G, Salkin I (1990) Evaluation of the updated Vitek yeast identification data base. J. Clin. Microbiol. 28: 1938-1941.
8. Feen J, Segal H, Barland B, Denton D, Whisenant J, Chun H, et al (1994) Comparison of updated Vitek yeast biochemical card and API 20C yeast identification systems. J. Clin. Microbiol. 32: 1184-1187.
9. Giusiano G, Mangiaterra M (1998) Diferenciación e identificación presuntiva rápida de levaduras con el medio CHROMagar Candida. Rev. Arg. Microbiol. 30: 100-103.
10. Kitch TT, Jacobs MR, McGinnis MR, Applebaum PC (1996) Ability of Rapid Yeast Plus System to identify 304 clinically significant yeast within 5 hours. J. Clin. Microbiol. 34: 1069-1071.
11. Kwon Chung KJ, Bennet JE (1992) Medical Micology, Lea & Febiger, USA.
12. o edición López Libreros, Buenos Aires, Argentina.
13. Negroni R, Guelfand LI (1999) Manual de procedimientos para laboratorios de micología médica. En; Federación Bioquimica de la Provincia de Buenos Aires (Ed), ACTA Bioquímica Clínica Latinoamericana, Buenos Aires, p. 5-57.
14. Nguyen MH, Peaco JE, Morris AJ, Tanner DC, Nguyen MI, Snydman DR, et al (1996) Changing face of candidemia: emergence of non-C. albicans species and antifungal resistance. Am. J. Med. 100: 617-623.
15. Odds F, Bernaerts R (1994) CHROMagar C., a new diffe-rential isolation medium for presuntive identification of clinical important C. species. J. Clin. Microbiol. 32: 1923-1929.
16. Pfaller MA (1996) Nosocomial candidiasis: Emerging species, reservoirs and modes of transmission. Clin. Infect. Dis 22 (S2): S89-94.
17. Pfaller MA, Jones RN, Doren GV, Sader HS, Hollis RJ, Messer SA, for the SENTRY participant group (1998) International surveillance of bloodstream infection C. species: frecuency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the Unites States, Canada and South America for the SENTRY participant group J. Clin. Microbiol. 36: 1886-1889.
18. Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, Houston A, et al (2000) Bloodstream infectiion due to Candida species; susceptibities antimicrobial surveillance program in North American and Latin American, 1997-1998. Antimicrob. Agents Chemother. 44: 747-751.
19. Quindòs G, Alonso-Vargas A, Helou S, Arechavala A, Martin -Mazuelos E, Negroni R (2001) Evaluación micológica de un nuevo medio de cultivo cromógeno (Candida ID) para el aislamiento e identificación presuntiva de C. albicans y otras levaduras de interés médico. Rev. Iberoam. Micol. 18: 23-28.
20. Quindoz G, Vargas R, Helou S, Arechavala A, Mazuelos E, Negroni R (2001) Evaluación micológica de un nuevo medio de cultivo cromogeno (Candida ID) para el aislamiento e identificación presuntiva de C. albicans. Rev. Iberoam. Micol. 18: 23-28.
21. Rodero L, Davel G, Cordoba S, Soria M, Canteros C, Hochenfellner F y grupo EMIFN (1999) Estudio multicéntrico sobre Candidiasis Nosocomial en la República Argentina. Rev. Arg. Microbiol. 31: 114-119.
22. Saral R (1991) Candida y Aspergillus infections in immuno-compromised patients: an overview. Rev. Infect. Dis. 13: 487-492.
23. San-Millan R, Ribacoba L, Ponton J, Quindos G (1996) Evaluation of commercial mbdium for identification of Candida species. Eur. J. Clin. Microbiol. Infect. Dis. 15: 153-158.
24. St. Germain G, Beauchesne D (1991) Evaluation of the MicroScan rapid yeast identification panel. J. Clin. Microbiol. 29: 2296-2299.
25. Wadlin JL, Hanko G, Stewart R, Pape J, Nachamkin I (1999) Comparison of three commercial systems for identification of yeast commonly isolated in the clinical microbiology laboratory. J. Clin. Microbiol. 37: 1967-1970.
26. th ed ASM Press, Washington D.C, p 723-737.
27. Wenzel RP (1995) Nosocomial candidemia: risk factors and atributable mortality. Clin. Infect. Dis. 20: 1531-1534.
28. Wickerham LJ, Burton S (1948) Carbonhydrate assimilation tests for the classification of yeasts. J. Bacteriol. 56: 363-371.
29. Wingard JR (1995) Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20: 115-125.